Skip to main content
Equibles

UBS Group AG

Position in ACB — Aurora Cannabis Inc

CIK 1610520 ZURICH, V8
Back to ACB Full portfolio

Position in ACB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$495,394
-$2,521 QoQ
Shares Held
177,561
+16.6% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#6
of 149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACB Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. ACB ranks #47 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,643,241 $261,803,294
2 ELAN
Elanco Animal Health Inc
 9,910,822 $243,905,327
3 UTHR
UNITED THERAPEUTICS Corp
 220,616 $119,536,366
4 VTRS
Viatris Inc
 6,092,296 $96,745,659
5 LNTH
Lantheus Holdings, Inc.
 835,494 $92,689,703
6 HIMS
Hims & Hers Health, Inc.
 2,660,810 $92,250,281
7 NBIX
Neurocrine Biosciences Inc
 545,937 $92,012,220
8 TEVA
Teva Pharmaceutical Industries Ltd
 2,140,065 $72,505,400

All Filings in ACB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $495,394 177,561
2026-03-31 $497,915 152,268
2025-12-31 $388,533 92,070
2025-09-30 $1,097,772 184,190
2025-06-30 $329,867 77,799
2025-03-31 $540,364 123,090
2024-12-31 $265,790 62,539
2024-09-30 $1,339 228
2024-06-30 $270,295 58,506
2024-03-31 $1,078 246
2023-12-31 $2,109 4,434
2023-09-30 $146,075 249,704
2023-06-30 $4,396 8,218
2023-03-31 $22,054 31,643
2022-12-31 $75,099 81,365
2022-09-30 $75,168 61,614
2022-06-30 $344,185 260,747
2022-03-31 $1,023,096 255,774
2021-12-31 $1,089,469 201,381
2021-09-30 $1,593,287 230,244
2021-06-30 $2,134,912 236,163
2021-03-31 $1,939,839 208,361
2020-12-31 $1,679,217 202,072
2020-09-30 $478,991 103,009
2020-06-30 $1,219,121 98,158
2020-03-31 $113,708 125,508